Effects of isotretinoin on bone mineralization during routine therapy with isotretinoin for acne vulgaris

Archives of Dermatology

Volumn 132, Issue 7, 1996, Pages 769-774

  Margolis, David J ^a   Attie, Maurice ^a   Leyden, James J ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; CALCIUM; HYDROXYPROLINE; ISOTRETINOIN; OSTEOCALCIN; PARATHYROID HORMONE;

ACNE VULGARIS; ADULT; ARTICLE; BONE ATROPHY; BONE MINERALIZATION; CALCIUM HOMEOSTASIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HIP; HUMAN; LUMBAR SPINE; MALE; OSTEOPOROSIS; PRIORITY JOURNAL;

EID: 0029950571     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.1996.03890310053007     Document Type: Article

References (40)

1. Leyden JJ. Retinoid and acne. J Am Acad Dermatol. 1988;19:164-168.
2. Teelman K. Retinoid: toxicology and teratogenicity to date Pharmacol Ther. 1989;40:29-43.
3. Kamm JJ. Toxicology, carcinogenicity and teratogenicity of some orally administered retinoids. J Am Acad Dermatol. 1982;6:652-659.
4. Bigby M, Stern RS. Adverse reactions to isotretinoin. J Am Acad Dermatol. 1988;18:543-552.
5. Goulden V, Layton AM, Cunliffe WJ. Long-term safety of isotretinoin as a treatment for acne vulgaris. Br J Dermatol. 1994;131:360-363.
6. Dai WS, LaBraico JM, Stern RS. Epidemiology of isotretinoin exposure during pregnancy. J Am Acad Dermatol. 1992;26:599-606.
7. Mitchell AA, Van Bennekom CM, Louik C. A pregnancy prevention program in women of childbearing age receiving isotretinoin. N Engl J Med 1995;333: 101-106.
8. White SI, Mackie RM. Bone changes associated with oral retinoid therapy. Pharmacol Ther. 1989;40:137-144.
9. Melnick B, Gluck S, Jungblut RM, Goerz G. Retrospective radiographic study of skeletal changes alter long-term etretinate therapy. Br J Dermatol. 1987; 116:207-212.
10. McGuire J, Lawson JP. Skeletal changes associated with chronic isotretinoin and etretinate administration. Dermatologica. 1987;173:169-181.
11. Kilcoyne RF, Lope R, Cunningham W, et al. Minimal spinal hyperostosis with low dose isotretinoin therapy. Invest Radiol. 1986;21:41-44.
12. Torok L, Galuska L, Kasa M, Kadar L. Bone scintigrachic examinations in patients treated with retinoid: a prospective study. Br J Dermatol. 1989;120:31-36.
13. Lawson JP, McGuire J. The spectrum of skeletal changes associated with long term administration of 13-cis-retinoic acid Skeletal Radiol. 1987;16:91-97.
14. Tangrea JA, Kilcoyne RF, Taylor PR. et al. Skeletal hyperostosis in patients receiving chronic, very low dose isotretinoin Arch Dermatol 1992;128:921-925.
15. Milstone LM, McGuire J. Ablow RC. Premature epiphyseal closure in a child receiving oral 13-cis-retinoic acid. J Am Acad Dermatol. 1982;7:663.
16. Wolbach SB. Vitamin-A deficiency and excess in relation to skeletal growth. J Bone Joint Surg. 1947;29:171-192.
17. Trechsel U, Stutzer A, Fleisch H. Hypercalcemia induced with an arotinoid in thyroparathyroidectomized rats. J Clin Invest 1987;80:1679-1686.
18. Teelman K. Comparative toxicity of oral all-trans-retinoic acid and aromatic retinoid. Drug Dev Res. 1983;3:49-57.
19. Ellis CN, Voortiees JJ. Etretinate therapy. J Am Acad Dermatol. 1987;16:267-291.
20. Nussey SS, Hyer SL, Brada M, Leiper AD. Bone mineralization after treatment of growth hormone deficiency in survivors of childhood malignancy. Acta Paediatr. 1994;399:9-14.
21. Katzman DK. Bachrach LK, Carter DR, Marcus R. Clinical and anthropometric correlates of bone mineral acquisition in healthy adolescent girls. J Clin Endocrinol Metab. 1991;73:1332-1339.
22. Bronner F. Calcium and osteoporosis. Am J Clin Nutr. 1994;60:831-836.
23. Ilich JZ, Hseieh LC, Tzagournis MA. et al A comparison of single photon and dual x-ray absorptiometry of the forearm in children and adults. Bone. 1994; 15:187-191.
24. Matkovic V. Calcium and peak bone mass. J Intern Med J. 1992;231:151-160.
25. Roland D, Aksnes L, Nilsen A, Morken T. Serum levels of vitamin D metabolites in isotretinoin-treated acne patients Acta Derm Venereol. 1992;72:217-219.
26. Mazess R, Collick B, Tremis J, Braden H, Hanson J. Performance evaluation of a dual energy x-ray densitometer Calcif Tissue Int. 1989;44:228-232.
27. Lee AH, Mull RL, Keenan GF. et al. Osteoporosis and bone morbidity in cardiac transplant recipients. Am J Med 1994;96:35-41.
28. Block G, Hartman AM, Dresser CM, Carroll MD, Cannon J, Gardner L. A data-based approach to diet questionnaire design and testing. Am J Epidemiol. 1986; 124:453-469.
29. Musgrave KO, Giambalvo L, Leclere HL, Cook RA, Rosen CJ. Validation of a quantitative food frequency questionnaire for rapid assessment of dietary calcium intake. J Am Diet Assoc. 1989;89:1484-1488.
30. O'Fallon WM. Clinical Trials in Bone Research: Statistical Considerations Anaheim, Calif: American Society for Bone Mineral Research; 1986.
31. Resch A, Schneider B, Bernecker P. et al. Risk of vertebral fractures in men: relationship to mineral density of the vertebral body. Am J Radiol. 1995;164: 1447-1450.
32. Bagur A, Vega E, Mautalen C. Discrimination of total body bone mineral density measured by Dexa in vertebral osteoporosis. Calcif Tissue Int. 1995;56: 263-267.
33. Gilsanz V, Gibbens DT, Carlson M, Boechat I, Cann CE, Schulz EE. Peak trabecular vertebral density: a comparison of adolescent and adult females Calcif Tissue Int. 1988;43:260-262.
34. Cauley JA, Seeley DG, Ensurd K, Ettinger B, Black D, Cummings SR. Estrogen replacement therapy and fractures in older women Ann Intern Med 1995; 122:9-16.
35. Pastuszak A, Koren G, Reider MJ. Use of the retinoid pregnancy prevention program in Canada patterns of contraception use in women treated with isotretinoin and etretinate. Reprod Toxicol. 1994;8:63-68.
36. DiGiovanna JJ, Sollitto RB, Abangan DL, Steinberg SM, Reynolds JC. Osteoporosis is a toxic effect of long-term etretinate therapy Arch Dermatol. 1995; 131:1263-1267.
37. Chesney RW, Rosen JF, Hamstra AJ, Smith C, Mahaffey K, DeLuca HF. Absence of seasonal variation in serum concentrations of 1,25-dihydroxyvitamin D despite a rise in 25-hydroxyvitamin D in summer. J Clin Endocrinol Metab. 1981;53:139-142.
38. Neer RM, Davis TRA, Walcott A, et al. Stimulation by artificial lighting of calcium absorption in elderly human subjects. Nature. 1995;229:255-257.
39. Ortego-Centeno N, Munoz-Torres M, Hernandez-Duero J. Jurado-Duce A. de al Higuera Torres-Puchol J. Bone mineral density, sex steroids, and mineral metabolism in premenopausal smokers. Calcif Tissue Int. 1994;55:403-407.
40. Allison P Using panel data to estimate effects of events. Sociol Methods Res. 1994;23:179-199.